First reports of serious adverse drug reactions in recent weeks

  • PDF / 86,232 Bytes
  • 2 Pages / 612.28 x 790.87 pts Page_size
  • 52 Downloads / 341 Views

DOWNLOAD

REPORT


First reports of serious adverse drug reactions in recent weeks The following table contains an overview of first published case reports of serious adverse drug reactions identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. An event is serious (US FDA MedWatch definition) when the patient outcome is death, life threatening, hospitalization, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage. Reactions and the custo-

mized Reactions Pharmacovigilance Service are produced by Adis, and monitor >4000 journals, including relevant MEDLINE- and EMBASE-indexed journals, as well as companion journal supplements, major scientific meetings, the newsletters from the >80 national centres participating in the WHO International Drug Monitoring Programme, media releases, pharmaceutical company websites, and regulatory agency websites.

Drug and serious adverse reaction

Reference

Acemetacin: Kounis syndrome

Akyel A, Murat SN, Cay S, et al. Late drug eluting stent thrombosis due to acemetacine: type III Kounis syndrome: Kounis syndrome due to acemetacine. Int J Cardiol 2012; 155 (3): 461-2

Aciclovir: Jarisch-Herxheimer reaction

Bottieau E, Verbruggen E, Aubry C, et al. Meningoencephalitis complicating relapsing fever in traveler returning from Senegal. Emerg Infect Dis 2011; 18 (4): 697-8

Adalimumab: Trichosporon asahii pulmonary infection

Songcharoen S, Cleary JD, Jenkins J, et al. T. asahii pulmonary infection as a complication of TNF-inhibitor and steroids: posaconazole pharmacotherapy and risk analysis. J Miss State Med Assoc 2011; 52 (11): 339-43

Albendazole: acute dystonic reaction in a child

Incecik F, Hergu¨ner MO, Ozcan K,et al. Albendazole-induced dystonic reaction: a case report. Turk J Pediatr 2011; 53 (6): 709-10

Amiodarone: Volkmann’s-like syndrome

Simoni P, Scarciolla L, Mare´chal C, et al. Cordarone extravasation inducing Volkmann’s-like syndrome. Cardiol Res 2011; 2 (6): 307-9

Anakinra: hypertriglyceridaemia

Lutz V, Lipsker D. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra. Arch Dermatol 2012; 148 (3): 297-99

Azacitidine: autoimmunity and sarcoidosis aggravation

Kotsianidis I, Spanoudakis E, Nakou E, et al. Hypomethylating therapy and autoimmunity in MDS: an enigmatic relationship. Leuk Res 2012; 36 (4): e90-2

Azacitidine: splenic rupture?

Forghieri F, Morselli M, Leonardi G, et al. Atraumatic splenic rupture in patients with myelodysplastic syndromes: report of a case occurred during treatment with 5-azacitidine and review of the literature. Leuk Res 2012; 36 (3): e52-6

Benoxaprofen: malignant melanoma

Chin KY, El-Kayat B, Milne A, et al. Melanoma diagnosed 27 years after a benoxaprofen-induced photosensitivity reaction. J Dermatol Case Rep 2012; 6 (1): 5-7

Betamethasone: cardiopulmonary arrest in an elderly patient

Stauber B, Ma L, Nazari R. Cardiopulmonary arrest following cervica